Todd Rider of the Massachusetts Institute of Technology’s Lincoln Laboratory in Lexington, Massachusetts, and his colleagues have been working on proteins in combination to find a way of destroying cells infected by a virus.
This could have far reaching impacts with viruses from the common cold right through to the HIV virus possibly being able to be cured.
“The new drug targets a molecule common to all virus-infected cells. Nearly every virus generates strings of double-stranded RNA longer than 30 base pairs during transcription and replication, in an attempt to duplicate itself and commandeer its host cell’s machinery. Healthy mammalian cells do not produce double-stranded RNA longer than 23 base pairs.”